The IGF-I peptide analog JB-1 was able to inhibit the autophosphorylation of the IGF-I receptor by IGF-I as well as the growth of several different cell types, including prostate carcinoma cells and SV40-transformed cells. IGF1 analogs as JB-1 might be useful in treating abnormal cell growth.